Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-31

Clinical Trial Update: Lubiprostone for Treatment of Chronic Idiopathic Constipation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for lubiprostone in chronic idiopathic constipation has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUBIPROSTONE (lubiprostone)

Snippet

Sponsor: Takeda | Conditions: Chronic Idiopathic Constipation | Phase 3 | Status: COMPLETED | Results posted: 2018-12-31